β-catenin regulates multiple steps of RNA metabolism as revealed by the RNA aptamer in colon cancer cells

被引:44
作者
Lee, Hee Kyu
Kwak, Ho Yoon
Hur, Jung
Kim, In Ae
Yang, Ji Sun
Park, Min Woo
Yu, Jaehoon
Jeong, Sunjoo [1 ]
机构
[1] Dankook Univ, Inst Nanosensor & Biotechnol, Dept Mol Biol, Grad Program RNA Biol BK21, Seoul, South Korea
[2] Seoul Natl Univ, Dept Chem & Educ, Seoul 151, South Korea
关键词
D O I
10.1158/0008-5472.CAN-07-1128
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nuclear beta-catenin forms a transcription complex with TCF-4, which is implicated in colon cancer development and progression. Recently, we and others have shown that beta-catenin could be a regulator of RNA splicing and it also stabilizes the cyclooxygenase-2 (COX-2) mRNA. Here, we further explored the role of beta-catenin in the RNA metabolism in colon cancer cells. To specifically modulate the sulicellular functions of beta-catenin, we expressed the RNA aptamer in the form of RNA intramers with unique cellular localizations. The nucleus-expressed RNA intramer proved to be effective in reducing the protein-protein interaction between beta-catenin and TCF-4, thus shown to be a specific regulator of beta-catenin-activated transcription. It could also regulate the alternative splicing of EIA minigene in diverse colon cancer cell lines. In addition, we tested whether -catenin could stabilize any other mRNAs and found that cyclin D I mRNA was also bound and stabilized by beta-catenin. Significantly, the cytoplasm expressed RNA intramer reverted the beta-catenin-induced COX-2 and cyclin D1 mRNA stabilization. We show here that beta-catenin regulated multiple steps of RNA metabolism in colon cancer cells and might be the protein factor coordinating RNA metabolism. We suggest that the RNA intramers could provide useful ways for inhibiting beta-catenin-mediated transcription and RNA metabolism, which might further enhance the antitumorigenic effects of these molecules in colon cancer cells.
引用
收藏
页码:9315 / 9321
页数:7
相关论文
共 33 条
[1]   Functional interaction of beta-catenin with the transcription factor LEF-1 [J].
Behrens, J ;
vonKries, JP ;
Kuhl, M ;
Bruhn, L ;
Wedlich, D ;
Grosschedl, R ;
Birchmeier, W .
NATURE, 1996, 382 (6592) :638-642
[2]   The mRNA assembly line: transcription and processing machines in the same factory [J].
Bentley, D .
CURRENT OPINION IN CELL BIOLOGY, 2002, 14 (03) :336-342
[3]   Cytoplasmic RNA modulators of an inside-out signal-transduction cascade [J].
Blind, M ;
Kolanus, W ;
Famulok, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) :3606-3610
[4]   The Wnt/β-catenin→Pitx2 pathway controls the turnover of Pitx2 and other unstable mRNAs [J].
Briata, P ;
Ilengo, C ;
Corte, G ;
Moroni, C ;
Rosenfeld, MG ;
Chen, CY ;
Gherzi, R .
MOLECULAR CELL, 2003, 12 (05) :1201-1211
[5]  
Brody E N, 2000, J Biotechnol, V74, P5, DOI 10.1016/S1389-0352(99)00004-5
[6]   Intracellular expression of the T-cell factor-1 RNA aptamer as an intramer [J].
Choi, Kang Hyun ;
Park, Min Woo ;
Lee, Seung Yeon ;
Jeon, Mi-Ya ;
Kim, Mee Young ;
Lee, Hee Kyu ;
Yu, Jaehoon ;
Kim, Hong-Jin ;
Han, Kyungsook ;
Lee, Heviran ;
Parks, Keerang ;
Park, Woong June ;
Jeong, Sunjoo .
MOLECULAR CANCER THERAPEUTICS, 2006, 5 (09) :2428-2434
[7]   Wnt/β-catenin signaling in development and disease [J].
Clevers, Hans .
CELL, 2006, 127 (03) :469-480
[8]   Wnt/β-catenin-pathway as a molecular target for future anti-cancer therapeutics [J].
Dihlmann, S ;
Doeberitz, MVK .
INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (04) :515-524
[9]   Intramers and aptamers: Applications in protein-function analyses and potential for drug screening [J].
Famulok, M ;
Mayer, G .
CHEMBIOCHEM, 2005, 6 (01) :19-26
[10]   Identification of c-MYC as a target of the APC pathway [J].
He, TC ;
Sparks, AB ;
Rago, C ;
Hermeking, H ;
Zawel, L ;
da Costa, LT ;
Morin, PJ ;
Vogelstein, B ;
Kinzler, KW .
SCIENCE, 1998, 281 (5382) :1509-1512